---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-039434"
form_type: "8-K"
ticker: "NSPR"
cik: "0001433607"
company_name: "InspireMD, Inc."
filed_at: "2023-11-06T23:59:59+00:00"
generated_at: "2026-06-08T19:33:20.771266+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# InspireMD Q3 revenue +8.8% to $1.56M; CMS expands CAS coverage; trial results positive

## Summary
- Q3 revenue $1.556M (+8.8% YoY); gross margin 28.1% (vs 25.6% Q3 2022).
- Net loss $5.178M ($0.15/diluted share) vs $4.529M ($0.58) in Q3 2022; cash $43.0M.
- Positive 30-day C-GUARDIANS IDE results: major adverse events (death/stroke/MI) rate 0.95% at VIVA23.
- CMS final NCD expanded CAS coverage to asymptomatic & standard risk patients, broadening addressable market.
- Leadership additions: Patrick Verta EVP Clinical, Cheryl Tal VP QA/RA; Shane Gleason promoted to CCO.

## SEC filing metadata
- accession: 0001493152-23-039434
- form_type: 8-K
- ticker: NSPR
- cik: 0001433607
- company_name: InspireMD, Inc.
- filed_at: 2023-11-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1433607/000149315223039434/0001493152-23-039434-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1433607/000149315223039434/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-039434
- JSON: https://secwatch.observer/filing/0001493152-23-039434.json
- Plain text: https://secwatch.observer/filing/0001493152-23-039434.txt

## Key facts
- Earnings Releases
  InspireMD, Inc. reported financial results for three and nine months ended September 30, 2023.
  - Period: three and nine months ended September 30, 2023
  - Result: reported results
  source text: On November 6, 2023, InspireMD, Inc. issued a press release announcing its financial and operating results and recent highlights for the three and nine months ended September 30, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1433607/000149315223039434/0001493152-23-039434-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.